Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TE MEDIC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.2% 7.0% 2.9% 6.8% 7.7% 0.0% 18.4% 18.4%   Credit score (0-100)   58 36 60 37 32 0 7 7   Credit rating   BBB BBB BBB BBB BB N/A B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,258 10.5 1,249 79.1 323 0.0 0.0 0.0   EBITDA   930 -323 801 -347 -81.0 0.0 0.0 0.0   EBIT   915 -339 798 -347 -81.0 0.0 0.0 0.0   Pre-tax profit (PTP)   861.3 -309.0 788.6 -344.2 -96.8 0.0 0.0 0.0   Net earnings   669.4 -309.6 680.8 -271.0 -170.0 0.0 0.0 0.0   Pre-tax profit without non-rec. items   861 -309 789 -344 -96.8 0.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   934 374 1,055 284 114 0.0 0.0 0.0   Interest-bearing liabilities   53.1 300 0.0 555 530 0.0 0.0 0.0   Balance sheet total (assets)   1,423 898 1,718 955 815 0.0 0.0 0.0   Net Debt   -226 249 -430 555 434 0.0 0.0 0.0     See the entire balance sheet 1000.0 Volume  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,258 10.5 1,249 79.1 323 0.0 0.0 0.0   Gross profit growth   0.0% -99.2% 11,767.8% -93.7% 307.9% -100.0% 0.0% 0.0%   Employees   1 1 1 1 1 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,423 898 1,718 955 815 0 0 0   Balance sheet change%   0.0% -36.9% 91.3% -44.4% -14.6% -100.0% 0.0% 0.0%   Added value   930.1 -322.7 801.0 -347.4 -81.0 0.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -15 -16 -3 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 -1.0 -2.0 0.0 0.0 0.0   1000.0 Profitability  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   72.7% -3,221.3% 63.8% -438.9% -25.1% 0.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   64.8% -26.3% 61.9% -25.0% -7.3% 0.0% 0.0% 0.0%   ROI %   93.4% -36.8% 93.6% -35.3% -8.8% 0.0% 0.0% 0.0%   ROE %   71.7% -47.3% 95.2% -40.5% -85.3% 0.0% 0.0% 0.0%   1000.0 Solidity  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A Equity ratio %   65.6% 41.7% 75.9% 29.8% 14.0% 0.0% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -24.3% -77.1% -53.6% -159.8% -535.7% 0.0% 0.0% 0.0%   Gearing %   5.7% 80.2% 0.0% 195.3% 464.2% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   229.7% 2.0% 14.2% 3.4% 5.8% 0.0% 0.0% 0.0%   1000.0 Liquidity  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A Quick Ratio   4.1 1.3 7.0 1.2 0.9 0.0 0.0 0.0   Current Ratio   4.7 1.7 3.0 1.4 1.1 0.0 0.0 0.0   Cash and cash equivalent   279.1 51.6 429.5 0.0 96.1 0.0 0.0 0.0   1000.0 Capital use efficiency  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,094.9 343.4 1,132.0 253.2 83.2 0.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 N/A 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   930 -323 801 -347 -81 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   930 -323 801 -347 -81 0 0 0   EBIT / employee   915 -339 798 -347 -81 0 0 0   Net earnings / employee   669 -310 681 -271 -170 0 0 0